Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JAZZ | RGC | BMRN | ||
| Company | Jazz Pharma Plc | Regencell Bioscience Holdings Ltd | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 182.84 | 22.35 | 57.69 | ||
| High | 183.99 | 22.45 | 58.00 | ||
| Low | 182.79 | 22.35 | 57.43 | ||
| Latest | 182.07 | 22.45 | 58.01 | ||
| Change | +0.05 | -0.23 | +0.58 | ||
| % Change | +0.03% | -1.01% | +1.01% | ||
| Volume | 9,166 | 4,722 | 39,128 | ||
| 20-Day Average Volume | 1,104,484 | 102,246 | 2,192,475 | ||
| Previous Close | 182.02 | 22.68 | 57.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 182.22 | 25.80 | 60.70 | ||
| 20-Day Raw Stochastic | 48.34% | 17.11% | 14.40% | ||
| 20-Day Relative Strength | 55.18 | 44.16 | 43.37 | ||
| Weighted Alpha | +39.05 | +6.13 | -13.98 | ||
| Today's Opinion | 88% Buy | 24% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 56% Buy | ||
| Last Month's Opinion | 40% Buy | 96% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.22% since 03/10/26 | -8.32% since 03/10/26 | -5.80% since 03/10/26 | ||
| Low | 177.58 on 03/13/26 | 22.30 on 03/16/26 | 55.86 on 03/16/26 | ||
| High | 186.00 on 03/11/26 | 25.53 on 03/11/26 | 61.26 on 03/11/26 | ||
| 1-Month | |||||
| %Chg | +8.23% since 02/17/26 | -28.82% since 02/17/26 | -4.32% since 02/17/26 | ||
| Low | 166.64 on 02/18/26 | 20.00 on 03/09/26 | 55.86 on 03/16/26 | ||
| High | 198.00 on 02/26/26 | 34.44 on 02/19/26 | 66.28 on 02/24/26 | ||
| 3-Month | |||||
| %Chg | +10.24% since 12/17/25 | +33.67% since 12/17/25 | +10.73% since 12/17/25 | ||
| Low | 156.95 on 01/08/26 | 16.90 on 12/18/25 | 51.50 on 12/18/25 | ||
| High | 198.00 on 02/26/26 | 69.00 on 01/08/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +40.34% since 09/17/25 | +44.04% since 09/17/25 | +5.50% since 09/17/25 | ||
| Low | 125.79 on 09/29/25 | 10.33 on 11/25/25 | 50.76 on 11/07/25 | ||
| High | 198.00 on 02/26/26 | 69.00 on 01/08/26 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,205,151 | 11,215,011 | 11,045,109 | ||
| Shares Outstanding, K | 61,560 | 494,489 | 192,323 | ||
| Annual Sales | 4,267,590,000 | 0 | 3,221,250,000 | ||
| Annual Net Income | -356,150,000 | -3,580,000 | 348,900,000 | ||
| Last Quarter Sales | 1,197,930,000 | N/A | 874,560,000 | ||
| Last Quarter Net Income | 203,450,000 | N/A | -46,570,000 | ||
| 60-Month Beta | 0.22 | 2.09 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 6.64 on 02/24/26 | N/A | 0.46 on 02/23/26 | ||
| Latest Earnings Date | 05/05/26 | 01/30/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 41.72 | 0.00 | 24.08 | ||